EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

STK11 overexpression alleviates diabetic atherosclerosis and inhibits ferroptosis, with concomitant AMPK pathway activation

Ying Miao, Yu Wang, Qin Wan, Nanwei Tong

Cell Biology and Toxicology · 16.11.2026

DOI: 10.1007/s10565-026-10331-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology and Toxicology, online erschienen am 16.11.2026. Verfasst von Ying Miao und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Luzhou Medical Association, Science and Technology Bureau of Luzhou City.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ferroptosis drives lipid peroxidation and inflammation in diabetic atherosclerosis (AS), while its role within this disease context remains unclarified. This study aims to identify potential markers of diabetic AS and characterize pathway changes associated with ferroptosis.

Methods

Ferroptosis-related genes were identified by integrating the GSE79623 dataset and a ferroptosis gene set. Streptozotocin-induced ApoE-/- mice received tail-vein serine/threonine kinase 11 (STK11)-overexpressing lentiviral vectors. Transcriptome sequencing identified STK11 overexpression-associated genes and enriched pathways. Mouse aortic endothelial cells (MAECs) were exposed to high glucose (HG) + oxidized low-density lipoprotein (ox-LDL), with STK11 overexpression, STK11 siRNA knockdown, adenosine monophosphate-activated protein kinase (AMPK) inhibitor dorsomorphin, or ferroptosis inhibitor ferrostatin-1 (Fer-1) treatment. Ferroptosis, lipid profiles, inflammation, and macrophage polarization were assessed.

Results

STK11, a ferroptosis-related gene, was downregulated in diabetic AS, while its overexpression was accompanied by ameliorated aortic injury, inhibited inflammation and lipid deposition, and suppressed ferroptosis, evidenced by decreased Fe^2+, malondialdehyde (MDA), and reactive oxygen species (ROS), with increased glutathione (GSH), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11) in mice. A total of 963 STK11 overexpression-associated differentially expressed genes (DEGs) were enriched in the AMPK signaling pathway. STK11 overexpression raised AMPKα/β and acetyl-CoA carboxylase (ACC) phosphorylation, reduced apoptosis and lipid droplets, and suppressed ferroptosis, and these phenotypic shifts were partially abrogated upon STK11 knockdown or dorsomorphin treatment. Fer-1 treatment phenocopied the phenotype of STK11 overexpression.

Conclusion

STK11 overexpression modulates ferroptosis associated with AMPK pathway activation and correlates with reduced diabetic atherosclerotic burden, advancing our understanding of diabetic atherosclerosis.

Förderung

  • Luzhou Medical Association
  • Science and Technology Bureau of Luzhou City

Zitieren

APA

Miao, Y., Wang, Y., Wan, Q., & Tong, N. (2026). STK11 overexpression alleviates diabetic atherosclerosis and inhibits ferroptosis, with concomitant AMPK pathway activation. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10331-8

Vancouver

Miao Y, Wang Y, Wan Q, Tong N. STK11 overexpression alleviates diabetic atherosclerosis and inhibits ferroptosis, with concomitant AMPK pathway activation. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10331-8

BibTeX
@article{Miao2026,
  author = {Miao, Ying and Wang, Yu and Wan, Qin and Tong, Nanwei},
  title = {STK11 overexpression alleviates diabetic atherosclerosis and inhibits ferroptosis, with concomitant AMPK pathway activation},
  journal = {Cell Biology and Toxicology},
  year = {2026},
  doi = {10.1007/s10565-026-10331-8}
}
Kostenlos starten →